Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
NPJ Regenerative Medicine
|
January 3, 2026
Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity
Laura Palmieri, Giorgia Bimbi, Maxime Ferrand, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 25, 2026
CRISPR-Cas9-Mediated Upregulation of Utrophin Ameliorates Duchenne Muscular Dystrophy
Maëlle Ralu, Simon Guiraud, Sumitava Dastidar, et al.
Nanomedicine (London, England)
|
June 10, 2014
Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy
Ruthger W van Zwieten, Stefania Puttini, Małgorzata Lekka, et al.
Plos One
|
February 19, 2013
Distinctive serum miRNA profile in mouse models of striated muscular pathologies
Nicolas Vignier, Fatima Amor, Paul Fogel, et al.
Plos One
|
June 6, 2012
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy
William Lostal, Marc Bartoli, Carinne Roudaut, et al.
Neuromuscular Disorders : NMD
|
January 24, 2007
A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay
Astrid Milic, Nathalie Daniele, Hanns Lochmüller, et al.
Annals of Clinical and Translational Neurology
|
April 21, 2020
A new congenital multicore titinopathy associated with fast myosin heavy chain deficiency
Aurélien Perrin, Corinne Metay, Marcello Villanova, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Modeling Sarcoglycanopathy in <i>Danio rerio</i>
Francesco Dalla Barba, Michela Soardi, Leila Mouhib, et al.
Science Translational Medicine
|
September 24, 2010
A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy
Martin Krahn, Nicolas Wein, Marc Bartoli, et al.
Science Translational Medicine
|
November 29, 2019
Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A
William Lostal, Carinne Roudaut, Marine Faivre, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
NPJ Regenerative Medicine
|
January 3, 2026
Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity
Laura Palmieri, Giorgia Bimbi, Maxime Ferrand, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 25, 2026
CRISPR-Cas9-Mediated Upregulation of Utrophin Ameliorates Duchenne Muscular Dystrophy
Maëlle Ralu, Simon Guiraud, Sumitava Dastidar, et al.
Nanomedicine (London, England)
|
June 10, 2014
Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy
Ruthger W van Zwieten, Stefania Puttini, Małgorzata Lekka, et al.
Plos One
|
February 19, 2013
Distinctive serum miRNA profile in mouse models of striated muscular pathologies
Nicolas Vignier, Fatima Amor, Paul Fogel, et al.
Plos One
|
June 6, 2012
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy
William Lostal, Marc Bartoli, Carinne Roudaut, et al.
Neuromuscular Disorders : NMD
|
January 24, 2007
A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay
Astrid Milic, Nathalie Daniele, Hanns Lochmüller, et al.
Annals of Clinical and Translational Neurology
|
April 21, 2020
A new congenital multicore titinopathy associated with fast myosin heavy chain deficiency
Aurélien Perrin, Corinne Metay, Marcello Villanova, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Modeling Sarcoglycanopathy in <i>Danio rerio</i>
Francesco Dalla Barba, Michela Soardi, Leila Mouhib, et al.
Science Translational Medicine
|
September 24, 2010
A naturally occurring human minidysferlin protein repairs sarcolemmal lesions in a mouse model of dysferlinopathy
Martin Krahn, Nicolas Wein, Marc Bartoli, et al.
Science Translational Medicine
|
November 29, 2019
Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A
William Lostal, Carinne Roudaut, Marine Faivre, et al.
Page
of 19